PTPA and type 2 diabetes nephropathy: Investigating the AdipoRon role in preventing type 2 diabetic nephropathy in db/db mice, Choi and colleagues observed a robust downregulation in both protein phosphatase 2A (PP2A) and ceramide levels, which resulted in ceramide-to-sphingosine-1 phosphate ratio normalization [77].